Cardinal Health (NYSE:CAH) Stock Rating Cut to Buy at Wall Street Zen

Cardinal Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Cardinal Health from “strong buy” to “buy.” Overall, analysts maintain a “Moderate Buy” consensus with an average price target of $290.13.
  • Recent analyst price targets include $295 from RBC and $304 from TD Cowen; JPMorgan raised its target to $286 while keeping a “neutral” rating.
  • Cardinal Health beat quarterly expectations, reporting EPS of $3.26 versus $2.94 expected and revenue of $67.51 billion versus $66.67 billion; revenue rose 5.5% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Cardinal Health (NYSE:CAH - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.

Several other analysts also recently issued reports on CAH. Royal Bank Of Canada raised their price target on Cardinal Health from $276.00 to $295.00 and gave the stock an "outperform" rating in a report on Friday, November 6th. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $260.00 to $286.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 10th. TD Cowen boosted their price target on shares of Cardinal Health from $280.00 to $304.00 and gave the company a "buy" rating in a report on Monday, November 9th. Leerink Partners set a $292.00 price target on shares of Cardinal Health in a research report on Tuesday, August 11th. Finally, Weiss Ratings upgraded shares of Cardinal Health from a "buy (b+)" rating to a "buy (a-)" rating in a research report on Monday, November 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average price target of $290.13.

Get Our Latest Report on CAH

Cardinal Health Stock Performance

Cardinal Health stock opened at $272.67 on Friday. Cardinal Health has a 1 year low of $180.45 and a 1 year high of $286.29. The firm's 50-day moving average is $247.94 and its 200-day moving average is $226.81. The company has a market cap of $63.03 billion, a P/E ratio of 35.27, a PEG ratio of 2.17 and a beta of 0.53.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping the consensus estimate of $2.94 by $0.32. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. During the same quarter in the prior year, the business earned $2.55 earnings per share. Cardinal Health's quarterly revenue was up 5.5% on a year-over-year basis. As a group, sell-side analysts predict that Cardinal Health will post 12.96 earnings per share for the current year.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors have recently added to or reduced their stakes in CAH. Defiance ETFs LLC lifted its holdings in shares of Cardinal Health by 50.2% in the third quarter. Defiance ETFs LLC now owns 1,421 shares of the company's stock valued at $315,000 after buying an additional 475 shares during the period. Kestra Advisory Services LLC grew its holdings in Cardinal Health by 58.2% during the third quarter. Kestra Advisory Services LLC now owns 25,470 shares of the company's stock worth $5,667,000 after acquiring an additional 9,369 shares during the period. Advisors Asset Management Inc. acquired a new position in Cardinal Health during the third quarter worth about $2,078,000. DGS Capital Management LLC raised its position in Cardinal Health by 21.9% in the third quarter. DGS Capital Management LLC now owns 1,666 shares of the company's stock worth $371,000 after acquiring an additional 299 shares in the last quarter. Finally, Innovator Capital Management LLC bought a new stake in Cardinal Health in the third quarter worth about $2,869,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company's businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Featured Articles

Analyst Recommendations for Cardinal Health (NYSE:CAH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines